Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P. Dec 15, 2025 05:05PM
Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P. Nov 13, 2025 08:47PM
Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P. Oct 1, 2024 05:47PM
Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P. Jun 21, 2022 04:36PM
WAVE Life Sciences (WVE) Announces Pricing of $70.0 Million Underwritten Offering Jun 14, 2022 09:00AM


Jun 14, 2022 09:00AM Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering
Jun 14, 2022 09:00AM Wave Life Sciences Announces Pricing of $70.0 Million Underwritten Offering
Nov 12, 2021 04:33PM Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 18, 2021 05:30PM Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 28, 2019 04:34PM Form 4 Wave Life Sciences Ltd. For: Jan 24 Filed by: RA CAPITAL MANAGEMENT, LLC
Jan 28, 2019 04:33PM Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 15, 2017 04:43PM Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
Jan 5, 2017 10:13AM Satsuma Pharmaceuticals Spins Out from Shin Nippon Biomedical Laboratories (SNBL) with Funding from Leading Institutional Life Science Investors
Nov 27, 2015 01:18PM Form SC 13D Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 18, 2015 05:30PM Form 4 Wave Life Sciences Ltd. For: Aug 14 Filed by: RA CAPITAL MANAGEMENT, LLC